Institute of Human Virology Nigeria (IHVN) was established in 2004 to address the HIV/AIDS crisis in Nigeria. It has since expanded its services to include TB, malaria, and cancer, aiming to develop infrastructure for treatment, care, prevention, and support. IHVN collaborates with local and international organizations, aligning with the Government of Nigeria's health sector plans. Key partners include the Centers for Disease Control and Prevention (CDC) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
As a Health Care focused organization, IHVN tackles infectious diseases in Nigeria. Although specific details about the company's headquarter location and recent investment are not provided, IHVN's strategic approach and collaborative network make it a promising prospect for investors looking to support healthcare initiatives in Nigeria. The organization's expansion beyond HIV/AIDS to other critical health concerns presents potential opportunities for impact and growth.
There is no investment information
No recent news or press coverage available for Institute of Human Virology Nigeria.